Financing ·
RedHill Biopharma closed a private placement of 8,571,429 ADSs and accompanying warrants, raising approximately $6…
RDHLRedHill Biopharma Ltd.
RedHill Biopharma closed a private placement of 8,571,429 ADSs and accompanying warrants, raising approximately $6 million in upfront gross proceeds. The offering included Series A-1 warrants with an $0.86 exercise price and Series A-2 warrants with a $0.70 exercise price, which could provide up to $13.4 million in additional gross proceeds upon full exercise. RedHill Biopharma is a specialty biopharmaceutical company focused on the development and commercialization of drugs for gastrointestinal, infectious, and oncology diseases.